Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 19, 2007
J Am Soc Nephrol 19: 213-216, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007080854
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007080854v1
19/2/213    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moe, S. M.
Right arrow Articles by Chen, N. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moe, S. M.
Right arrow Articles by Chen, N. X.

Science in Renal Medicine

Mechanisms of Vascular Calcification in Chronic Kidney Disease

Sharon M. Moe and Neal X. Chen

Department of Medicine, Indiana University, Indianapolis, Indiana

Correspondence: Dr. Sharon M. Moe, Professor of Medicine, Department of Medicine, Indiana University, 1001 W. 10th Street, OPW 526, Indianapolis, IN 46202. Phone: 317-278-2868; Fax: 317-278-2860; E-mail: smoe{at}iupui.edu

Vascular calcification is common in chronic kidney disease and associated with increased morbidity and mortality. Its mechanism is multifactorial and incompletely understood. Patients with chronic kidney disease are at risk for vascular calcification because of multiple risk factors that induce vascular smooth muscle cells to change into a chondrocyte or osteoblast-like cell; high total body burden of calcium and phosphorus due to abnormal bone metabolism; low levels of circulating and locally produced inhibitors; impaired renal excretion; and current therapies. Together these factors increase risk and complicate the management of vascular calcification.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. Palmer and G. Strippoli
Reply: Vitamin D compounds in chronic kidney disease: change may be needed for good!
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1789 - 1792.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673